Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Fulgent Genetics setting itself up to add growth, says Piper Sandler » 04:36
05/23/22
05/23
04:36
05/23/22
04:36
FLGT

Fulgent Genetics

$56.06 /

-1.59 (-2.76%)

Piper Sandler analyst…

Piper Sandler analyst David Westenberg reiterates an Overweight rating on Fulgent Genetics with a $70 price target after hosting meetings with management. The analyst came away "impressed" with the company's core growth, potential in its COVID business, and "optionality" with its $1.1B in cash. He believes Fulgent is setting itself up to add growth via acquisitions, particularly as other labs struggle with cash management.

ShowHide Related Items >><<
FLGT Fulgent Genetics
$56.06 /

-1.59 (-2.76%)

FLGT Fulgent Genetics
$56.06 /

-1.59 (-2.76%)

05/15/22 Piper Sandler
Fulgent Genetics price target lowered to $70 from $85 at Piper Sandler
03/01/22 Piper Sandler
Fulgent Genetics price target raised to $85 from $80 at Piper Sandler
02/04/22 Piper Sandler
Fulgent Genetics assumed with an Overweight at Piper Sandler
01/25/22 Oppenheimer
Fulgent Genetics price target lowered to $125 from $141 at Oppenheimer
FLGT Fulgent Genetics
$56.06 /

-1.59 (-2.76%)

FLGT Fulgent Genetics
$56.06 /

-1.59 (-2.76%)

Conference/Events
Fulgent Genetics management to meet with Piper Sandler » 04:55
05/20/22
05/20
04:55
05/20/22
04:55
FLGT

Fulgent Genetics

$57.63 /

+2.22 (+4.01%)

Meetings to be held in…

Meetings to be held in New York on May 17-20 hosted by Piper Sandler.

ShowHide Related Items >><<
FLGT Fulgent Genetics
$57.63 /

+2.22 (+4.01%)

FLGT Fulgent Genetics
$57.63 /

+2.22 (+4.01%)

05/15/22 Piper Sandler
Fulgent Genetics price target lowered to $70 from $85 at Piper Sandler
03/01/22 Piper Sandler
Fulgent Genetics price target raised to $85 from $80 at Piper Sandler
02/04/22 Piper Sandler
Fulgent Genetics assumed with an Overweight at Piper Sandler
01/25/22 Oppenheimer
Fulgent Genetics price target lowered to $125 from $141 at Oppenheimer
FLGT Fulgent Genetics
$57.63 /

+2.22 (+4.01%)

FLGT Fulgent Genetics
$57.63 /

+2.22 (+4.01%)

Conference/Events
Fulgent Genetics management to meet with Piper Sandler » 04:55
05/19/22
05/19
04:55
05/19/22
04:55
FLGT

Fulgent Genetics

$55.51 /

-0.69 (-1.23%)

Meetings to be held in…

Meetings to be held in New York on May 17-20 hosted by Piper Sandler.

ShowHide Related Items >><<
FLGT Fulgent Genetics
$55.51 /

-0.69 (-1.23%)

FLGT Fulgent Genetics
$55.51 /

-0.69 (-1.23%)

05/15/22 Piper Sandler
Fulgent Genetics price target lowered to $70 from $85 at Piper Sandler
03/01/22 Piper Sandler
Fulgent Genetics price target raised to $85 from $80 at Piper Sandler
02/04/22 Piper Sandler
Fulgent Genetics assumed with an Overweight at Piper Sandler
01/25/22 Oppenheimer
Fulgent Genetics price target lowered to $125 from $141 at Oppenheimer
FLGT Fulgent Genetics
$55.51 /

-0.69 (-1.23%)

FLGT Fulgent Genetics
$55.51 /

-0.69 (-1.23%)

Conference/Events
Fulgent Genetics management to meet with Piper Sandler » 04:55
05/18/22
05/18
04:55
05/18/22
04:55
FLGT

Fulgent Genetics

$56.76 /

+3.18 (+5.94%)

Meetings to be held in…

Meetings to be held in New York on May 17-20 hosted by Piper Sandler.

ShowHide Related Items >><<
FLGT Fulgent Genetics
$56.76 /

+3.18 (+5.94%)

FLGT Fulgent Genetics
$56.76 /

+3.18 (+5.94%)

05/15/22 Piper Sandler
Fulgent Genetics price target lowered to $70 from $85 at Piper Sandler
03/01/22 Piper Sandler
Fulgent Genetics price target raised to $85 from $80 at Piper Sandler
02/04/22 Piper Sandler
Fulgent Genetics assumed with an Overweight at Piper Sandler
01/25/22 Oppenheimer
Fulgent Genetics price target lowered to $125 from $141 at Oppenheimer
FLGT Fulgent Genetics
$56.76 /

+3.18 (+5.94%)

FLGT Fulgent Genetics
$56.76 /

+3.18 (+5.94%)

Conference/Events
Fulgent Genetics management to meet with Piper Sandler » 04:55
05/17/22
05/17
04:55
05/17/22
04:55
FLGT

Fulgent Genetics

$53.66 /

-0.8 (-1.47%)

Meetings to be held in…

Meetings to be held in New York on May 17-20 hosted by Piper Sandler.

ShowHide Related Items >><<
FLGT Fulgent Genetics
$53.66 /

-0.8 (-1.47%)

FLGT Fulgent Genetics
$53.66 /

-0.8 (-1.47%)

05/15/22 Piper Sandler
Fulgent Genetics price target lowered to $70 from $85 at Piper Sandler
03/01/22 Piper Sandler
Fulgent Genetics price target raised to $85 from $80 at Piper Sandler
02/04/22 Piper Sandler
Fulgent Genetics assumed with an Overweight at Piper Sandler
01/25/22 Oppenheimer
Fulgent Genetics price target lowered to $125 from $141 at Oppenheimer
FLGT Fulgent Genetics
$53.66 /

-0.8 (-1.47%)

FLGT Fulgent Genetics
$53.66 /

-0.8 (-1.47%)

Conference/Events
Fulgent Genetics management to meet with Piper Sandler » 16:04
05/16/22
05/16
16:04
05/16/22
16:04
FLGT

Fulgent Genetics

$53.27 /

-1.19 (-2.19%)

Meetings to be held in…

Meetings to be held in New York on May 17-20 hosted by Piper Sandler.

ShowHide Related Items >><<
FLGT Fulgent Genetics
$53.27 /

-1.19 (-2.19%)

FLGT Fulgent Genetics
$53.27 /

-1.19 (-2.19%)

05/15/22 Piper Sandler
Fulgent Genetics price target lowered to $70 from $85 at Piper Sandler
03/01/22 Piper Sandler
Fulgent Genetics price target raised to $85 from $80 at Piper Sandler
02/04/22 Piper Sandler
Fulgent Genetics assumed with an Overweight at Piper Sandler
01/25/22 Oppenheimer
Fulgent Genetics price target lowered to $125 from $141 at Oppenheimer
FLGT Fulgent Genetics
$53.27 /

-1.19 (-2.19%)

FLGT Fulgent Genetics
$53.27 /

-1.19 (-2.19%)

Recommendations
Fulgent Genetics price target lowered to $70 from $85 at Piper Sandler » 21:14
05/15/22
05/15
21:14
05/15/22
21:14
FLGT

Fulgent Genetics

$54.43 /

+2.85 (+5.53%)

Piper Sandler analyst…

Piper Sandler analyst David Westenberg lowered the firm's price target on Fulgent Genetics to $70 from $85 and keeps an Overweight rating on the shares post the earnings release. The analyst dropped price targets in the life science tools and genomics space to reflect movements in comp valuations.

ShowHide Related Items >><<
FLGT Fulgent Genetics
$54.43 /

+2.85 (+5.53%)

FLGT Fulgent Genetics
$54.43 /

+2.85 (+5.53%)

03/01/22 Piper Sandler
Fulgent Genetics price target raised to $85 from $80 at Piper Sandler
02/04/22 Piper Sandler
Fulgent Genetics assumed with an Overweight at Piper Sandler
01/25/22 Oppenheimer
Fulgent Genetics price target lowered to $125 from $141 at Oppenheimer
08/10/21 Piper Sandler
Fulgent Genetics should be bought on post-earnings weakness, says Piper Sandler
FLGT Fulgent Genetics
$54.43 /

+2.85 (+5.53%)

FLGT Fulgent Genetics
$54.43 /

+2.85 (+5.53%)

Hot Stocks
Fulgent Genetics announces promotions, leadership updates » 16:35
05/03/22
05/03
16:35
05/03/22
16:35
FLGT

Fulgent Genetics

$56.70 /

+0.7 (+1.25%)

Fulgent Genetics…

Fulgent Genetics announced a number of promotions and appointments across its leadership team. James Xie, Fulgent's Chief Operating Officer, has been named President in addition to his current role. Chris Wicker has been appointed as Vice President and General Manager of CSI Laboratories and Inform Diagnostics. Wicker was formerly the Chief Executive Officer and Chief Financial Officer of CSI and joined Fulgent through the company's acquisition in August, 2021. Natalie Prescott has joined Fulgent Genetics as Vice President of Legal and Deputy General Counsel. Ellen Tsui has been promoted to Vice President of Human Resources. Tsui joined Fulgent in April 2018 as the Company's Human Resources Manager.

ShowHide Related Items >><<
FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

03/01/22 Piper Sandler
Fulgent Genetics price target raised to $85 from $80 at Piper Sandler
02/04/22 Piper Sandler
Fulgent Genetics assumed with an Overweight at Piper Sandler
01/25/22 Oppenheimer
Fulgent Genetics price target lowered to $125 from $141 at Oppenheimer
08/10/21 Piper Sandler
Fulgent Genetics should be bought on post-earnings weakness, says Piper Sandler
FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

Earnings
Fulgent Genetics cuts FY22 EPS guidance to $6.00 from $7.00 » 16:25
05/03/22
05/03
16:25
05/03/22
16:25
FLGT

Fulgent Genetics

$56.70 /

+0.7 (+1.25%)

Cuts FY22 revenue view to…

Cuts FY22 revenue view to approximately $660M, compared to previous guidance of $600M

ShowHide Related Items >><<
FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

03/01/22 Piper Sandler
Fulgent Genetics price target raised to $85 from $80 at Piper Sandler
02/04/22 Piper Sandler
Fulgent Genetics assumed with an Overweight at Piper Sandler
01/25/22 Oppenheimer
Fulgent Genetics price target lowered to $125 from $141 at Oppenheimer
08/10/21 Piper Sandler
Fulgent Genetics should be bought on post-earnings weakness, says Piper Sandler
FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

Earnings
Fulgent Genetics sees Q2 revenue $125M » 16:25
05/03/22
05/03
16:25
05/03/22
16:25
FLGT

Fulgent Genetics

$56.70 /

+0.7 (+1.25%)

Sees Q2 Core Revenue of…

Sees Q2 Core Revenue of approximately $40M, representing growth of 78% year-over-year

ShowHide Related Items >><<
FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

03/01/22 Piper Sandler
Fulgent Genetics price target raised to $85 from $80 at Piper Sandler
02/04/22 Piper Sandler
Fulgent Genetics assumed with an Overweight at Piper Sandler
01/25/22 Oppenheimer
Fulgent Genetics price target lowered to $125 from $141 at Oppenheimer
08/10/21 Piper Sandler
Fulgent Genetics should be bought on post-earnings weakness, says Piper Sandler
FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

FLGT Fulgent Genetics
$56.70 /

+0.7 (+1.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.